mutation: be related to cancer development

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents variation
Weight: 0.58
, event
Weight: 0.57
, factor
Weight: 0.53
, thing
Weight: 0.53
, concept
Weight: 0.51
Siblings polymorphism
Weight: 0.54
, translocation
Weight: 0.45
, gene
Weight: 0.34
, genotype
Weight: 0.33
, atherosclerosis
Weight: 0.32

Related properties

Property Similarity
be related to cancer development 1.00
cause cancer 0.87
lead to cancer 0.82
lead to skin cancer 0.79
be in p53 lead to cancers 0.79
cause disease 0.78
be related 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.38
Rule weight: 0.66
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.71
Plausible(factor, be related)
Evidence: 0.84
¬ Typical(mutation, be related to cancer development)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.89
Similarity weight: 0.76
Evidence: 0.84
Plausible(mutation, be related to cancer development)
Evidence: 0.71
¬ Plausible(factor, be related)

Remarkability exclusitivity betweem a parent and a child

0.18
Rule weight: 0.58
Evidence weight: 0.41
Similarity weight: 0.76
Evidence: 0.78
¬ Remarkable(mutation, be related to cancer development)
Evidence: 0.76
¬ Remarkable(factor, be related)

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.46
Similarity weight: 0.78
Evidence: 0.78
¬ Remarkable(mutation, be related to cancer development)
Evidence: 0.69
¬ Remarkable(gene, cause disease)
0.04
Rule weight: 0.13
Evidence weight: 0.40
Similarity weight: 0.76
Evidence: 0.78
¬ Remarkable(mutation, be related to cancer development)
Evidence: 0.77
¬ Remarkable(genotype, be related)
0.04
Rule weight: 0.13
Evidence weight: 0.40
Similarity weight: 0.76
Evidence: 0.78
¬ Remarkable(mutation, be related to cancer development)
Evidence: 0.77
¬ Remarkable(gene, be related)

Remarkability from parent implausibility

0.30
Rule weight: 0.42
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.71
Plausible(factor, be related)
Evidence: 0.78
Remarkable(mutation, be related to cancer development)
Evidence: 0.84
¬ Plausible(mutation, be related to cancer development)

Remarkability from sibling implausibility

0.45
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.78
Evidence: 0.84
Plausible(mutation, be related to cancer development)
Evidence: 0.69
Remarkable(gene, cause disease)
Evidence: 0.59
¬ Plausible(gene, cause disease)
0.44
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.84
Plausible(mutation, be related to cancer development)
Evidence: 0.77
Remarkable(gene, be related)
Evidence: 0.64
¬ Plausible(gene, be related)
0.44
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.76
Evidence: 0.84
Plausible(mutation, be related to cancer development)
Evidence: 0.77
Remarkable(genotype, be related)
Evidence: 0.68
¬ Plausible(genotype, be related)

Salient implies Plausible

0.24
Rule weight: 0.28
Evidence weight: 0.85
Similarity weight: 1.00
Evidence: 0.84
Plausible(mutation, be related to cancer development)
Evidence: 0.93
¬ Salient(mutation, be related to cancer development)

Similarity expansion

0.71
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.87
Evidence: 0.93
Salient(mutation, be related to cancer development)
Evidence: 0.71
¬ Salient(mutation, cause cancer)
0.66
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.87
Evidence: 0.84
Plausible(mutation, be related to cancer development)
Evidence: 0.68
¬ Plausible(mutation, cause cancer)
0.66
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.82
Evidence: 0.93
Salient(mutation, be related to cancer development)
Evidence: 0.91
¬ Salient(mutation, lead to cancer)
0.65
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.87
Evidence: 0.84
Typical(mutation, be related to cancer development)
Evidence: 0.75
¬ Typical(mutation, cause cancer)
0.65
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.84
Typical(mutation, be related to cancer development)
Evidence: 0.15
¬ Typical(mutation, cause disease)
0.65
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.87
Evidence: 0.78
Remarkable(mutation, be related to cancer development)
Evidence: 0.57
¬ Remarkable(mutation, cause cancer)
0.64
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.78
Evidence: 0.93
Salient(mutation, be related to cancer development)
Evidence: 0.43
¬ Salient(mutation, cause disease)
0.64
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.79
Evidence: 0.93
Salient(mutation, be related to cancer development)
Evidence: 0.95
¬ Salient(mutation, lead to skin cancer)
0.63
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.78
Evidence: 0.84
Plausible(mutation, be related to cancer development)
Evidence: 0.30
¬ Plausible(mutation, cause disease)
0.62
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.76
Evidence: 0.93
Salient(mutation, be related to cancer development)
Evidence: 0.68
¬ Salient(mutation, be related)
0.61
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.84
Typical(mutation, be related to cancer development)
Evidence: 0.32
¬ Typical(mutation, be related)
0.61
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.82
Evidence: 0.78
Remarkable(mutation, be related to cancer development)
Evidence: 0.60
¬ Remarkable(mutation, lead to cancer)
0.60
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.82
Evidence: 0.84
Plausible(mutation, be related to cancer development)
Evidence: 0.88
¬ Plausible(mutation, lead to cancer)
0.60
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.82
Evidence: 0.84
Typical(mutation, be related to cancer development)
Evidence: 0.93
¬ Typical(mutation, lead to cancer)
0.60
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.76
Evidence: 0.84
Plausible(mutation, be related to cancer development)
Evidence: 0.47
¬ Plausible(mutation, be related)
0.59
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.79
Evidence: 0.78
Remarkable(mutation, be related to cancer development)
Evidence: 0.60
¬ Remarkable(mutation, lead to skin cancer)
0.58
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.79
Evidence: 0.84
Plausible(mutation, be related to cancer development)
Evidence: 0.92
¬ Plausible(mutation, lead to skin cancer)
0.57
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.79
Evidence: 0.84
Typical(mutation, be related to cancer development)
Evidence: 0.97
¬ Typical(mutation, lead to skin cancer)
0.54
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.78
Evidence: 0.78
Remarkable(mutation, be related to cancer development)
Evidence: 0.86
¬ Remarkable(mutation, cause disease)
0.52
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.76
Evidence: 0.78
Remarkable(mutation, be related to cancer development)
Evidence: 0.90
¬ Remarkable(mutation, be related)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.93
Salient(mutation, be related to cancer development)
Evidence: 0.84
¬ Typical(mutation, be related to cancer development)
Evidence: 0.78
¬ Remarkable(mutation, be related to cancer development)

Typical implies Plausible

0.42
Rule weight: 0.48
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.84
Plausible(mutation, be related to cancer development)
Evidence: 0.84
¬ Typical(mutation, be related to cancer development)

Typicality and Rermarkability incompatibility between a parent and a child

0.18
Rule weight: 0.51
Evidence weight: 0.46
Similarity weight: 0.76
Evidence: 0.78
¬ Remarkable(mutation, be related to cancer development)
Evidence: 0.69
¬ Typical(factor, be related)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.53
Similarity weight: 0.78
Evidence: 0.78
¬ Remarkable(mutation, be related to cancer development)
Evidence: 0.61
¬ Typical(gene, cause disease)
0.05
Rule weight: 0.14
Evidence weight: 0.52
Similarity weight: 0.76
Evidence: 0.78
¬ Remarkable(mutation, be related to cancer development)
Evidence: 0.62
¬ Typical(gene, be related)
0.05
Rule weight: 0.14
Evidence weight: 0.50
Similarity weight: 0.76
Evidence: 0.78
¬ Remarkable(mutation, be related to cancer development)
Evidence: 0.64
¬ Typical(genotype, be related)

Typicality inheritance from parent to child

0.33
Rule weight: 0.48
Evidence weight: 0.89
Similarity weight: 0.76
Evidence: 0.84
Typical(mutation, be related to cancer development)
Evidence: 0.69
¬ Typical(factor, be related)